PEDRO SALINAS HERNÁNDEZ; RAFAEL TRUJILLO VILCHEZ; ANTONIO ARRIVÍ GARCÍA-RAMOS; ROSANA GRANDE LADRON DE GUEVARA; ANGELES RODRÍGUEZ JARAIZ; PEDRO GALLURT MOREIRA; JOSE MARIA VIEITEZ DE PRADO; MIGUEL RUIZ LÓPEZ DE TEJADA; ANTONIO IRIGOYEN MEDINA; JUAN MANUEL CAMPOS CERVERA; JUAN CARLOS CÁMARA VICARIO; URIEL BOHN SARMIENTO; PEDRO LÓPEZ TENDERO; JUAN DOMINGO ALONSO LAJARA; ANA LEÓN CARBONERO; MARISA GARCÍA DE PAREDES; JUAN DE ALVARO LIAÑO; ASUNCIÓN JUAREZ MARROQUÍ; LUIS LÓPEZ GÓMEZ; DIEGO SOTO DE PRADO OTERO. Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study. Journal of Analytical Oncology, [S. l.], v. 2, n. 3, p.  128–134, 2013. DOI: 10.6000/1927-7229.2013.02.03.1. Disponível em: https://www.neoplasiaresearch.com/pms/index.php/jao/article/view/77. Acesso em: 13 oct. 2024.